Maryland’s high court halted a case that stymied the state’s medical cannabis industry, but it’s unclear what it means for companies aiming to get into the lucrative business. It’s also unclear how the original complaint –that the state’s licensing commission didn’t taking diversity into account in granting licenses— will be addressed. We get an update on the complicated issue of bringing medical marijuana to Maryland.

Guests

  • Fenit Nirappil Reporter, Washington Post @FenitN
  • Kate Bell Lawyer, Marijuana Policy Project

Topics + Tags

Comments

comments powered by Disqus
Most Recent Shows